Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Biochemical markers of bone metabolism and their importance].

Literature DB >> 27146404

[Biochemical markers of bone metabolism and their importance].

Abstract

Laboratory analyses of biochemical markers for bone and mineral metabolism can play a key role in the assessment of patients with osteoporosis. They may help to assess bone turnover in the diagnostic work-up and aid decision-making as well as selection of pharmaceutical therapy options. Recent publications on therapy response have shown that biochemical markers of bone turnover are valuable tools for the evaluation of therapy success in individual osteoporosis patients and the assessment of bone mineral density gain during therapy.

Entities: Disease Species

Keywords: Biomarkers; Laboratory analyses; Monitoring; Osteoporosis; Therapy

Mesh：

Substances：

Year: 2016 PMID： 27146404 DOI： 10.1007/s00393-016-0083-5

Source DB: PubMed Journal: Z Rheumatol ISSN： 0340-1855 Impact factor: 1.372

23 in total

1. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting.

Authors: P Qvist; S Christgau; B J Pedersen; A Schlemmer; C Christiansen
Journal: Bone Date: 2002-07 Impact factor: 4.398

Review 2. Physiological role of alkaline phosphatase explored in hypophosphatasia.

Authors: Michael P Whyte
Journal: Ann N Y Acad Sci Date: 2010-03 Impact factor: 5.691

3. Allelic determinants of vitamin d insufficiency, bone mineral density, and bone fractures.

Authors: Olivia Trummer; Verena Schwetz; Daniela Walter-Finell; Elisabeth Lerchbaum; Wilfried Renner; Markus Gugatschka; Harald Dobnig; Thomas R Pieber; Barbara Obermayer-Pietsch
Journal: J Clin Endocrinol Metab Date: 2012-04-24 Impact factor: 5.958

Review 4. Vitamin D deficiency.

Authors: Michael F Holick
Journal: N Engl J Med Date: 2007-07-19 Impact factor: 91.245

5. Mechanism of circadian variation in bone resorption.

Authors: N H Bjarnason; E E G Henriksen; P Alexandersen; S Christgau; D B Henriksen; C Christiansen
Journal: Bone Date: 2002-01 Impact factor: 4.398

6. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

Authors: Faryal S Mirza; I Desmond Padhi; Lawrence G Raisz; Joseph A Lorenzo
Journal: J Clin Endocrinol Metab Date: 2010-02-15 Impact factor: 5.958

Review 7. Role of Wnts in prostate cancer bone metastases.

Authors: Christopher L Hall; Sona Kang; Ormond A MacDougald; Evan T Keller
Journal: J Cell Biochem Date: 2006-03-01 Impact factor: 4.429

8. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors: Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal: N Engl J Med Date: 2007-05-03 Impact factor: 91.245

9. Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.

Authors: Barbara M Obermayer-Pietsch; Fernando Marin; Eugene V McCloskey; Peyman Hadji; Jordi Farrerons; Steven Boonen; Maurice Audran; Clare Barker; Athanasios D Anastasilakis; William D Fraser; Thomas Nickelsen
Journal: J Bone Miner Res Date: 2008-10 Impact factor: 6.741